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Abstract:  
Recent studies have established that, in benign tumors, a large number of cancer stem 
cells are present, which have great implications in tumor development. However, in 
ameloblastoma, a highly aggressive, locally invasive tumor with a high recurrence rate, 
whether or not cancer stem-like cells are present remains undetermined. Therefore, in 
this study we analyzed the protein expression of three candidate stem cell markers in 
ameloblastoma. Immunohistochemical staining for cancer stem cell (CSC) markers 
(CD133, CD44 and ABCG2) and for the proliferation marker Ki-67 was performed using 
23 ameloblastoma cases. In all 23 samples, CD 133, CD44 and ABCG2 were 
expressed. Nine (39.13%) cases showed high expression and 14 cases (60.87%) 
showed low expression for CD133. Twelve of the 23 cases (52.17%) showed high 
expression and 11 cases (47.83%) showed low expression for both CD44 and ABCG2, 
respectively. Ki-67 was mainly expressed in peripheral ameloblast-like cells, suggesting 
that these cells have a higher degree of differentiation and, therefore, are less likely to 
contain cancer stem-like cells. On the other hand, cells positive for CSC markers 
situated at the close proximity to peripheral cells were devoid of Ki-67 and may have the 
potential to be cancer stem-like cells. After analyzing the correlation between 
expression of three CSC markers with clinicopathological factors and Ki-67 expression, 
only CD44 expression was correlated with tumor recurrence (P=0.0391). In conclusion, 
this study showed various expression patterns of different types of cancer stem cell 
markers and the presence of candidate CSC-like cells in ameloblastoma, which are 
possibly involved in cell proliferation, tumor progression and recurrence. 
 
 
Author  Sathi, G. A. 
 Tamamura, R. 
 Tsujigiwa, H. 
 Katase, N. 
 Lefeuvre, M. 
 Siar, C. H. 
 Matsuda, H. 
 Nagatsuka, H. 
Source Experimental and Therapeutic Medicine 
ISSN 1792-0981 
DOI 10.3892/etm.2011.437 
Volume (Issue) 3(3) 
Page 397-402 
Year 2012 
Keyword: 
Ameloblastoma, cancer stem cell, CD133, CD44, ABCG2, Immunohistochemistry, 
prospective identification, carcinoma, invasion 
 
Please Cite As: 
SATHI, G. A., TAMAMURA, R., TSUJIGIWA, H., KATASE, N., LEFEUVRE, M., SIAR, 
C. H., MATSUDA, H. & NAGATSUKA, H. 2012. Analysis of immunoexpression of 
common cancer stem cell markers in ameloblastoma. Experimental and 
Therapeutic Medicine, 3, 397-402. 
 
URL: 
 http://apps.webofknowledge.com search via Accession No >> 000300340300006 
 http://www.ncbi.nlm.nih.gov/pubmed/22969902 
 http://www.spandidos-publications.com/10.3892/etm.2011.437 
 
